{"id":"W4389243136","doi":"10.1016/j.eururo.2023.11.015","title":"Reply to Lin Ding, Bin Yang, and Xudong Yao’s Letter to the Editor re: Fred Saad, Noel W. Clarke, Mototsugu Oya, et al. Olaparib plus Abiraterone Versus Placebo plus Abiraterone in Metastatic Castration-resistant Prostate Cancer (PROpel): Final Prespecified Overall Survival Results of a Randomised, Double-blind, Phase 3 Trial. Lancet Oncol 2023;24:1094–108","year":2023,"lang":"en","type":"letter","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Merck Sharp and Dohme; AstraZeneca","keywords":"Medicine; Abiraterone; Olaparib; Placebo; Internal medicine; Prostate cancer; Cancer; Pathology; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.004867405,0.001036675,0.002307193,0.0008876886,0.0002115805,0.0002525212,0.0007505744,0.0003784931,0.0001535878],"category_scores_gemma":[0.0008793658,0.0007477967,0.0002702522,0.0007955215,0.0003588018,0.0001855248,0.0005172572,0.00317018,0.0002043887],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006997667,"about_ca_system_score_gemma":0.001083061,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003050257,"about_ca_topic_score_gemma":0.003289973,"domain_scores_codex":[0.9895595,0.003383782,0.002161295,0.001996298,0.001354322,0.001544815],"domain_scores_gemma":[0.9952743,0.001556823,0.000873097,0.001475958,0.0004143445,0.0004054956],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.4854951,0.000150914,0.000007136099,0.0001840287,0.0004647708,0.002696424,0.001105655,0.0004593962,0.001374558,9.129529e-7,0.5078261,0.000234998],"study_design_scores_gemma":[0.4649913,0.005322926,0.0001432113,0.0002590089,0.0003560708,0.00001286554,0.00005313357,0.0001375774,0.0001890008,0.000001941535,0.5281073,0.0004256095],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"commentary","genre_scores_codex":[0.1698132,0.001386703,0.00004521843,0.7907016,0.009778474,0.02268091,0.003644855,0.0001788433,0.001770201],"genre_scores_gemma":[0.04728805,0.005149893,0.001058896,0.738035,0.06541251,0.01377251,0.01059829,0.001735672,0.1169492],"genre_candidate":"commentary","genre_consensus":"commentary","teacher_disagreement_score":0.1225251,"threshold_uncertainty_score":0.9994973,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1495319722172449,"score_gpt":0.3815436196601418,"score_spread":0.2320116474428969,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}